Edoxaban dose ranged from 15 mg to 60 mg , resulting in a two-fold to three fold gradient of mean trough drug exposure ( 160-485 ng/mL in 6780 patients with data available ) and mean trough anti-FXa activity ( 035-085 IU/mL in 2865 patients ) .